You are here
- Home
- Therapy Areas
- Cardiovascular
Interventions study for the control of diabetes mellitus type 2 in obese women
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Generic Name
- rosuvastatin
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Sep 1, 2005
- Study Name
- DM-CRESTOR-0001
- Study Id
- D3560L00018
- ClinicalTrials.gov ID
- NCT00262548
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
